Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Novel ovarian cancer maintenance therapy targeted at mortalin and mutant p53.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Novel ovarian cancer maintenance therapy targeted at mortalin and mutant p53.
Novel ovarian cancer maintenance therapy targeted at mortalin and mutant p53. Int J Cancer. 2020 08 15; 147(4):1086-1097.
View in:
PubMed
subject areas
Animals
Animals
Apoptosis
Apoptosis
Aza Compounds
Aza Compounds
Bridged Bicyclo Compounds, Heterocyclic
Bridged Bicyclo Compounds, Heterocyclic
Cell Line, Tumor
Cell Line, Tumor
Chromans
Chromans
Female
Female
HSP70 Heat-Shock Proteins
HSP70 Heat-Shock Proteins
Humans
Humans
Maintenance Chemotherapy
Maintenance Chemotherapy
Mice, Nude
Mice, Nude
Molecular Targeted Therapy
Molecular Targeted Therapy
Mutation
Mutation
Ovarian Neoplasms
Ovarian Neoplasms
Thiones
Thiones
Tumor Suppressor Protein p53
Tumor Suppressor Protein p53
Xenograft Model Antitumor Assays
Xenograft Model Antitumor Assays
authors with profiles
Yan Daniel Zhao
Doris M Benbrook
Sugantha Priya Elayapillai
Zitha Redempta Isingizwe
Amy Leigh Kennedy